Please join me for HLTH Europe where I’ll interview the CEOs of Compass Pathways & atai Life Sciences on “Transforming Perspectives on Psychedelics” Curious to hear any questions you’d like me to ask. See you in Amsterdam! Discount code in image.

I am honored to follow my friend and Co-Founder Florian in leading atai. I look forward to working as Co-CEOs through this year. We started atai to transform mental health care, and I’m grateful to continue this work. Thank you, Florian, the board, and the atai team for your

Today I’ll be doing a fireside chat with Andrew Tsai at #JefferiesHealthcare Conference in New York.  I'll discuss atai’s upcoming milestones & share thoughts on Tuesday's unprecedented FDA AdCom on MDMA-AT for PTSD. Sign up for live webcast & replay: ir.atai.life/news-events/ev…

Our management team will participate in the H.C. Wainwright & Co. Neuro Perspectives conference on Thursday June 27. Co-CEOs Srinivas G. Rao and Florian Brand will engage in a fireside chat which will be available on-demand from 7:00 am ET via the following link. journey.ct.events/view/9f6864bf-…. There will be

The Supreme Court has become consumed by a corruption crisis beyond its control. Today’s ruling represents an assault on American democracy. It is up to Congress to defend our nation from this authoritarian capture. I intend on filing articles of impeachment upon our return.

“In the end we only regret the chances we didn’t take.” Lewis Carrol (1832-1898), English logician, mathematician, photographer & novelist especially remembered for his novel "Alice’s Adventures in Wonderland" – which includes various hints towards #psychedelic experiences

One of the best posts I’ve read for a long time. Must-read for every founder. Don’t get gaslit by the managerial class. Under the disguise of “growing up” they’ll try to take over your company + likely end up doing more harm than good. Thank you Paul Graham paulgraham.com/foundermode.ht…

In our grand simulation, it's physics all the way down. So it seems poetic that the AI pioneers receive the Nobel Prize in physics. Intelligence and consciousness are emergent phenomena in a computationally irreducible matrix. But there is a more precise tie between the power

Tomorrow is World Mental Health Day, and in alignment with our core values, our team is taking the day off to rest, recharge and prioritize well-being. While it feels like a privilege to pause for mental health, the reality is—it shouldn't be. Everyone deserves access to

Excited to join this year’s #CNSSummit2024! Looking forward to sharing insights on 15 years of progress & the game-changing potential of psychedelics in mental health treatment.

Every day, over 300 million people face the struggle of depression. 1 in 3 find no relief in current treatment options. For those living with treatment-resistant depression, hope feels out of reach. We're proud to share the next video in our #OneBillionPeople series, highlighting

Treatment-resistant depression (TRD) affects 1/3 of those with depression and is marked by complex biological & genetic factors, making it unresponsive to standard treatments. Our latest #OneBillionPeople video highlights the critical unmet need in TRD.

Very happy to announce that my family office, Apeiron Investment Group, has invested USD 22.75 million into atai Life Sciences (Nasdaq: $ATAI), the #psychedelics biotech company I founded and chair, increasing Apeiron’s ownership stake from 19.9% to 22.3%. I personally believe that psychedelic

The first patient has been dosed in Elumina, our Ph2 trial of VLS-01 for TRD – an important milestone. With ~100M people affected and limited options, we focus on conditions with high unmet need. Looking forward to the data in Q1’26. ir.atai.life/news-releases/…

Q4 #Earnings highlights: Strong financial position following successful capital raise, with two Phase 2 trials underway & large Phase 2b results expected mid-2025. 🔗 bit.ly/4ioeENc #MentalHealth

#News: atai Life Sciences & Beckley Psytech have combined to form atai Beckley – Creating a global leader in psychedelic mental health therapies #mentalhealth therapies. Together, we’re accelerating innovation for those in need. Learn more: ir.atai.com/news-releases/… Join our

Prof. John Marsden (King’s College London) and Dr. Anya Ermakova (Beckley Psytech) will be sharing novel clinical and micro-phenomenological data from our Phase IIa study of BPL-003 for Alcohol Use Disorder at the 2025 CPDD Annual Meeting. 🔗 Learn more: beckleypsytech.com/posts/results-…